Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (7979)
All Articles published online
|
Publishing Process of This Article
|
Dec 26, 2017 (publication date) through Jan 5, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Stem Cells
ISSN
1948-0210
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Dorobantu M, Popa-Fotea NM, Popa M, Rusu I, Micheu MM. Pursuing meaningful end-points for stem cell therapy assessment in ischemic cardiac disease. World J Stem Cells 2017; 9(12): 203-218 [PMID: 29321822 DOI: 10.4252/wjsc.v9.i12.203] |
|---|---|
| URL: | https://www.wjgnet.com/1948-0210/full/v9/i12/203.htm |
| Number | Citing Articles |
| 1 |
Miruna Mihaela Micheu, Alina Ioana Scarlatescu, Alexandru Scafa-Udriste, Maria Dorobantu. The Winding Road of Cardiac Regeneration—Stem Cell Omics in the Spotlight. Cells 2018; 7(12): 255 doi: 10.3390/cells7120255
|
| 2 |
K. V. Dergilev, Iu. D. Vasilets, Z. I. Tsokolaeva, E. S. Zubkova, E. V. Parfenova. Perspectives of cell therapy for myocardial infarction and heart failure based on cardiosphere cells. Terapevticheskii arkhiv 2020; 92(4): 111 doi: 10.26442/00403660.2020.04.000634
|
| 3 |
Miruna Mihaela Micheu. Moving forward on the pathway of cell-based therapies in ischemic heart disease and heart failure – time for new recommendations?. World Journal of Stem Cells 2019; 11(8): 445-451 doi: 10.4252/wjsc.v11.i8.445
|
| 4 |
Babak Arjmand, Mina Abedi, Maryam Arabi, Sepideh Alavi-Moghadam, Mostafa Rezaei-Tavirani, Mahdieh Hadavandkhani, Akram Tayanloo-Beik, Ramin Kordi, Peyvand Parhizkar Roudsari, Bagher Larijani. Regenerative Medicine for the Treatment of Ischemic Heart Disease; Status and Future Perspectives. Frontiers in Cell and Developmental Biology 2021; 9 doi: 10.3389/fcell.2021.704903
|